NACASY

• Research type

  Research Study

• Full title

  Open label, multinational, multicentre, prospective, real world observational study of Naloxegol for patients with cancer pain diagnosed with Opioid Induced Constipation (OIC).

• IRAS ID

  245953

• Contact name

  Andrew Davies

• Contact email

  adavies12@nhs.net

• Sponsor organisation

  Kyowa Kirin International plc.

• Duration of Study in the UK

  1 years, 5 months, 16 days

• Research summary

  NACASY is an observational study for adult patients with Opioid Induced Constipation (OIC) receiving Naloxegol in routine clinical practice.
  Investigators will prescribe Naloxegol for a patient and at this moment the investigator will offer him/her the participation of the study. It means that patient will receive the same medication regardless of their participation in the study.
  Patient will be follow up during 4 weeks, and during the study they will need to evaluate their health using questionnaires.
  After study, patients could continue or not with Naloxegol treatment according to the opinion of investigator/doctor and his/her routine clinical practice.

• REC name

  London - Dulwich Research Ethics Committee

• REC reference

  18/LO/2056

• Date of REC Opinion

  18 Feb 2019

• REC opinion

  Further Information Favourable Opinion